Skip to content

Contact +44 (0) 20 7060 7474 email us

Healthcare

EPIX Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

 

Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 17
ISBN Number not applicable
Product Code GMD02325

Price

£83.00
approximately: $126 | €93

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

EPIX Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Epix Pharmaceuticals, Inc. (Epix) is a biopharmaceutical company, engaged in discovery, development and commercialization of novel medicines through its proprietary and highly efficient in silico drug discovery platform, for the treatment of various chronic diseases including cardiovascular disease, central nervous system, Alzheimer's disease, depression and cognitive impairment. The company is headquartered at Lexington in Massachusetts, United States.

Global Markets Direct's EPIX Pharmaceuticals, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of EPIX Pharmaceuticals, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

  • Provides key company information for business intelligence needs.
  • The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and financial and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitor's weaknesses and target the market opportunities available to them.
  • Compare your company's financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

  • Key Information
  • Key Ratios
  • Share Data
  • Performance Chart
  • List of Tables
  • List of Figures
    • Key Facts
    • Business Description
    • Major Products and Services
    • Overview
    • History
    • SWOT Analysis Overview
    • Overview
    • EPIX Pharmaceuticals, Inc. - Strengths
    • Sturdy Research and development activities
    • Strong financial position
    • EPIX Pharmaceuticals, Inc. - Weaknesses
    • Lack of manufacturing capabilities
    • Concentrated Revenues
    • EPIX Pharmaceuticals, Inc. - Opportunities
    • Acquisitions of Predix Pharmaceuticals
    • Rising Healthcare Expenditure in the US
    • Changing Demographics
    • EPIX Pharmaceuticals, Inc. - Threats
    • Issues related to the use of Gadolinium in imaging
    • Tightening of FDA's Regulatory Oversight
    • Impact of Financial Crisis
    • Key Competitors
    • Key Employees
    • Key Employee Biographies
    • Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
    • Financial Ratios
    • Capital Market Ratios
    • Annual Ratios
    • Interim Ratios
    • Ratio Charts
  • Appendix
    • Methodology
    • Ratio Definitions
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • EPIX Pharmaceuticals, Inc., Key Facts
    • EPIX Pharmaceuticals, Inc., Key Ratios
    • EPIX Pharmaceuticals, Inc., Share Data
    • EPIX Pharmaceuticals, Inc., Key Facts
    • EPIX Pharmaceuticals, Inc., History
    • EPIX Pharmaceuticals, Inc., Key Employees
    • EPIX Pharmaceuticals, Inc., Key Employee Biographies
    • EPIX Pharmaceuticals, Inc., Other Locations
    • EPIX Pharmaceuticals, Inc., Ratios based on current share price
    • EPIX Pharmaceuticals, Inc., Annual Ratios
    • EPIX Pharmaceuticals, Inc., Interim Ratios
    • Currency Codes
    • Capital Market Ratios
    • Equity Ratios
    • Profitability Ratios
    • Cost Ratios
    • Liquidity Ratios
    • Leverage Ratios
    • Efficiency Ratios
  • List of Figures
    • EPIX Pharmaceuticals, Inc., Performance Chart (2004 - 2008)
    • EPIX Pharmaceuticals, Inc., Ratio Charts
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Contains SWOT Analysis